22nd Century Group Inc (NASDAQ:XXII)

1.82
Delayed Data
As of Aug 12
 +0.02 / +1.11%
Today’s Change
1.42
Today|||52-Week Range
4.17
-41.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$390.9M

Company Description

22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.

Contact Information

22nd Century Group, Inc.
500 Seneca Street
Buffalo New York 14204
P:(716) 270-1523
Investor Relations:
(716) 300-1221

Employees

Shareholders

Other institutional8.43%
Mutual fund holders12.98%
Individual stakeholders12.12%

Top Executives

James A MishChief Executive Officer & Director
Michael J. ZercherPresident & Chief Operating Officer
Robert Hugh KinsmanChief Financial Officer
Juan Sanchez TamburrinoVice President-Research & Development
Calvin TreatChief Scientific Officer